Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy
Authors
Keywords
Lung and intrathoracic tumors, T cells, Cytotoxic T cells, Cancer vaccines, Non-small cell lung cancer, Flow cytometry, Cytokines, Cell staining
Journal
PLoS One
Volume 12, Issue 2, Pages e0171539
Publisher
Public Library of Science (PLoS)
Online
2017-02-11
DOI
10.1371/journal.pone.0171539
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Day 3 Poly (I:C)-activated dendritic cells generated in CellGro for use in cancer immunotherapy trials are fully comparable to standard Day 5 DCs
- (2014) Iva Truxova et al. IMMUNOLOGY LETTERS
- High hydrostatic pressure induces immunogenic cell death in human tumor cells
- (2014) Jitka Fucikova et al. INTERNATIONAL JOURNAL OF CANCER
- Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy
- (2014) Irena Adkins et al. OncoImmunology
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer
- (2012) Nadeem A. Sheikh et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- FDG PET scans as evaluation of clinical response to dendritic cell vaccination in patients with malignant melanoma
- (2012) Lotte Engell-Noerregaard et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- First clinical trial of cancer vaccine therapy with artificially synthesized helper/ killer-hybrid epitope long peptide of MAGE-A4 cancer antigen
- (2012) Norihiko Takahashi et al. CANCER SCIENCE
- Impact of dendritic cell vaccines pulsed with Wilms’ tumour-1 peptide antigen on the survival of patients with advanced non-small cell lung cancers
- (2012) Hidenori Takahashi et al. EUROPEAN JOURNAL OF CANCER
- Lipopolysaccharide-Activated Dendritic Cells: "Exhausted" or Alert and Waiting?
- (2012) K. Abdi et al. JOURNAL OF IMMUNOLOGY
- Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update on a Phase I/II Trial
- (2011) P. F. Brunsvig et al. CLINICAL CANCER RESEARCH
- Mature autologous dendritic cell vaccines in advanced non-small cell lung cancer: a phase I pilot study
- (2011) Maurício W Perroud et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Poly I: C-activated dendritic cells that were generated in CellGro for use in cancer immunotherapy trials
- (2011) Jitka Fučíková et al. Journal of Translational Medicine
- Vaccines for the treatment of non-small cell lung cancer: Investigational approaches and clinical experience
- (2011) Håkan Mellstedt et al. LUNG CANCER
- Enumeration of human antigen-specific naive CD8+ T cells reveals conserved precursor frequencies
- (2010) C. Alanio et al. BLOOD
- Co-expression patterns of tumor-associated antigen genes by non-small cell lung carcinomas: Implications for immunotherapy
- (2010) Vaios Karanikas et al. CANCER BIOLOGY & THERAPY
- Pilot Study of 1650-G: A Simplified Cellular Vaccine for Lung Cancer
- (2010) Edward A. Hirschowitz et al. Journal of Thoracic Oncology
- Phase I study of autologous dendritic cell tumor vaccine in patients with non-small cell lung cancer
- (2010) Soo-Jung Um et al. LUNG CANCER
- The role of CD40 and CD154/CD40L in dendritic cells
- (2009) Daphne Y. Ma et al. SEMINARS IN IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now